Middle East & Africa Overactive Bladder Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)

The Middle East & Africa overactive bladder treatment market is expected to grow from US$ 290.94 million in 2022 to US$ 330.17 million by 2028; it is estimated to grow at a CAGR of 2.1% from 2022 to 2028.

Increasing Number of Mergers and Acquisitions to Fuel Middle East & Africa Overactive Bladder Treatment Market in Coming Years

Through mergers and acquisitions (M&A), companies can gain a competitive edge by entering new markets and acquiring new technologies. The ongoing mergers and acquisitions in the overactive bladder treatment market are creating growth opportunities for various companies. In July 2021, Uro Medical strengthened its urology portfolio with the acquisition of Micron Medical, which offers wirelessly powered, injectable, microtechnology neurostimulators focused on treating overactive bladder. These neurostimulators, which can be easily incorporated into patients’ daily lives, offer a convenient, safe, minimally invasive, and cost-effective urological treatment option. In February 2021, Axonics Modulation Technologies, Inc.—a medical technology company—acquired Contura Ltd. and its proprietary product, Bulkamid, which is a urethral bulking agent for women with stress urinary incontinence (SUI). Axonics produces and markets novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction. The acquisition of Contura Ltd. provides an opportunity to expand its SNM business across the world and serve the large, highly underpenetrated SUI market. The company plans to offer urogynecologists and urologists a complete suite of clinically differentiated incontinence solutions to treat their patients. Thus, increasing number of mergers and acquisitions is propelling Middle East & Africa overactive bladder treatment market growth.

Middle East & Africa Overactive Bladder Treatment Market Overview

The Middle East & Africa overactive bladder treatment market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The market growth is attributed to the increasing prevalence of chronic diseases and growing medical research studies across the region. Urinary incontinence is a clinical condition that is observed more among women in Saudi Arabia. According to The Cureus Journal of Medical Science published in the National Library of Medicine, in 2022, the prevalence of urinary continence in Jeddah and Riyadh, Saudi Arabia, was estimated to be 41.4% and 29%, respectively. A few factors such as age, obesity, medical comorbidities, hysterectomy, and multiparity contribute to the occurrence of urinary incontinence condition. Further, multiple pregnancy cases and rise in the geriatric population are also a few factors contributing to the growth of the overactive bladder treatment market. Also, the rise in the prevalence of chronic diseases and the high demand for rapid diagnosis, effective treatment options, and preventive measures are boosting the market growth in Saudi Arabia. The Saudi Arabia Ministry of Health provides primary health services through 2,259 centers to ~13,455 people. The primary health center settings are the first in line that deals with emerging complaints such as urological-related problems. It helps assess knowledge and practice patterns regarding common urological problems observed by primary health centers physicians. Thus, aforementioned factors are anticipated to fuel the growth of the overactive bladder treatment market in the coming years.

Middle East & Africa Overactive Bladder Treatment Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Middle East & Africa Overactive Bladder Treatment Market Segmentation

The Middle East & Africa overactive bladder treatment market is segmented on the basis of pharmacotherapy, disease type, and country.

Based on pharmacotherapy, the Middle East & Africa overactive bladder treatment market is segmented into anticholinergics, mirabegron, botox, neurostimulation, and intravesical instillation. The mirabegron segment registered the largest share of the market in 2022.

Based on disease type, the Middle East & Africa overactive bladder treatment market is bifurcated into idiopathic overactive bladder and neurogenic bladder. The idiopathic overactive bladder segment held a larger share of the market in 2022.

Based on country, the Middle East & Africa overactive bladder treatment market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.

AbbVie Inc; Alembic Pharmaceuticals Limited; Astellas Pharma Inc; Endo Pharmaceuticals Inc.; Hisamitsu Pharmaceutical Co., Inc.; Medtronic Plc; Pfizer Inc; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Middle East & Africa overactive bladder treatment market.

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Overactive Bladder Treatment Market– By Pharmacotherapy

1.3.2 Middle East & Africa Overactive Bladder Treatment Market– By Disease Type

1.3.3 Middle East & Africa Overactive Bladder Treatment Market – By Country

2. Middle East & Africa Overactive Bladder Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Overactive Bladder Treatment Market – Market Landscape

4.1 Overview

4.2 Middle East & Africa PEST Analysis

4.3 Expert Opinion

5. Middle East & Africa Overactive Bladder Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Urinary Incontinence

5.1.2 Growing Incidence of Urinary Tract Infections

5.2 Key Market Restraints

5.2.1 Recalls of Therapeutic Drugs

5.3 Key Market Opportunities

5.3.1 Increasing Number of Mergers and Acquisitions

5.4 Future Trends

5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies

5.5 Impact analysis

6. Middle East & Africa Overactive Bladder Treatment Market – Middle East & Africa Analysis

6.1 Middle East & Africa Overactive Bladder Treatment Market Revenue Forecast and Analysis

7. Middle East & Africa Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Pharmacotherapy

7.1 Overview

7.2 Middle East & Africa Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)

7.3 Mirabegron

7.3.1 Overview

7.3.2 Mirabegron: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.4 Botox

7.4.1 Overview

7.4.2 Botox: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.5 Neurostimulation

7.5.1 Overview

7.5.2 Neurostimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.3 Transcutaneous Sacral Nerve Stimulation

7.5.3.1 Overview

7.5.3.2 Transcutaneous Sacral Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.4 Transcutaneous Tibial Nerve Stimulation

7.5.4.1 Overview

7.5.4.2 Transcutaneous Tibial Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.5 Percutaneous Posterior Tibial Nerve Stimulation

7.5.5.1 Overview

7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.6 Others

7.5.6.1 Overview

7.5.6.2 Others: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.6 Anticholinergics

7.6.1 Overview

7.6.2 Anticholinergics: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.3 Solifenacin

7.6.3.1 Overview

7.6.3.2 Solifenacin: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.4 Oxybutynin

7.6.4.1 Overview

7.6.4.2 Oxybutynin: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.5 Fesoterodine

7.6.5.1 Overview

7.6.5.2 Fesoterodine: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.6 Darifenacin

7.6.6.1 Overview

7.6.6.2 Darifenacin: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.7 Tolterodine

7.6.7.1 Overview

7.6.7.2 Tolterodine: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.8 Trospium

7.6.8.1 Overview

7.6.8.2 Trospium: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.9 Other Anticholinergics

7.6.9.1 Overview

7.6.9.2 Other Anticholinergics: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.7 Intravesical Instillation

7.7.1 Overview

7.7.2 Intravesical Instillation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8. Middle East & Africa Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Disease Type

8.1 Overview

8.2 Middle East & Africa Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)

8.3 Idiopathic Overactive Bladder

8.3.1 Overview

8.3.2 Idiopathic: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Neurogenic Overactive Bladder

8.4.1 Overview

8.4.2 Neurogenic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 – Country Analysis

9.1 Overview

9.1.1 Middle East & Africa: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.1.1.1 UAE: overactive bladder treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.1 UAE: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2 UAE: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.1.2.1 UAE: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.1.2.2 UAE Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.3 UAE: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.2 Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.2 Saudi Arabia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.2.2.1 Saudi Arabia: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.2.2.2 Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.3 Saudi Arabia: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.3 South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.1 South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.2 South Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.3.2.1 South Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.3.2.2 South Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3 South Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.4 Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.2 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.4.2.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.4.2.2 Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.3 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

10. Overactive Bladder Treatment Market– Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

11. Company Profiles

11.1 Alembic Pharmaceuticals Limited

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Astellas Pharma Inc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 AbbVie Inc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Teva Pharmaceutical Industries Ltd

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Endo Pharmaceuticals Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Hisamitsu Pharmaceutical Co.,Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Medtronic Plc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Pfizer Inc

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. UAE Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 2. UAE Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 3. UAE Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 4. UAE Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. Saudi Arabia Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 6. Saudi Arabia Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 7. Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 8. Saudi Arabia Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. South Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 10. South Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 11. South Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 12. South Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 13. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 14. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 15. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 17. Organic Developments Done by Companies

Table 18. Glossary of Terms

LIST OF FIGURES

Figure 1. Middle East & Africa Overactive Bladder Treatment Market Segmentation

Figure 2. Middle East & Africa Overactive Bladder Treatment Market Segmentation, By Country

Figure 3. Middle East & Africa Overactive Bladder Treatment Market Overview

Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in Middle East & Africa Overactive Bladder Treatment market

Figure 5. South Africa Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Middle East & Africa: PEST Analysis

Figure 7. Middle East & Africa Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints

Figure 8. Middle East & Africa Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9. Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)

Figure 10. Mirabegron: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 11. Botox: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Neurostimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Transcutaneous Sacral Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Transcutaneous Tibial Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ MN)

Figure 15. Percutaneous Posterior Tibial Nerve: Middle East & Africa Overactive Bladder Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 16. Others: Middle East & Africa Overactive Bladder Market Revenue and Forecasts To 2028 (US$ MN)

Figure 17. Anticholinergics: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Solifenacin: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Oxybutynin: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Fesoterodine: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Darifenacin: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Tolterodine: Middle East & Africa Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23. Trospium: Middle East & Africa Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Other Anticholinergics: Middle East & Africa Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Intravesical Instillation: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Middle East & Africa Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)

Figure 27. Idiopathic: Middle East & AfricaOveractive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. Neurogenic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Middle East & Africa: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 30. UAE: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa overactive bladder treatment market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa overactive bladder treatment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the overactive bladder treatment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000